Nutritional status and growth in Korean children with Crohn's disease: a single-center study

Seung Min Song1, Young Kim1, Seak Hee Oh1

  • 1Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.

Gut and Liver
|September 18, 2014
PubMed

Insights

Pediatric Crohn

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Nutrition
  • Inflammatory Bowel Disease Research

Background:

  • Malnutrition and growth retardation are significant challenges in pediatric Crohn's disease (CD) management.
  • Early identification of nutritional and growth issues is crucial for effective treatment.

Purpose of the Study:

  • To determine the prevalence of nutritional and growth abnormalities in Korean children diagnosed with CD.
  • To explore the relationship between these parameters and disease characteristics.

Main Methods:

  • Analysis of height-for-age (HAZ), weight-for-height (WHZ), body mass index for age (BMIZ), and bone mineral density for age (BMDZ) Z-scores in 71 pediatric CD patients.
  • Assessment of biochemical markers and correlation with disease activity, extent, and behavior.

Main Results:

  • High prevalence of abnormal growth parameters at diagnosis: 4% HAZ <-2, 28% WHZ <-2, 27% BMIZ <-2, 18% BMDZ <-2.
  • Subnormal levels of key nutrients (hemoglobin, albumin, iron, calcium, zinc, etc.) were common.
  • Lower HAZ in females and those with extraintestinal manifestations; lower WHZ/BMIZ in patients with stricturing/penetrating disease.

Conclusions:

  • Abnormal nutritional status and growth retardation are highly prevalent in Korean pediatric CD patients at diagnosis.
  • These abnormalities are significantly associated with disease extent, behavior, and activity.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
673
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
21
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
941
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
683